↓ Skip to main content

Diabetes - Perspectives in Drug Therapy

Overview of attention for book
Cover of 'Diabetes - Perspectives in Drug Therapy'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Targeting type 2 diabetes.
  3. Altmetric Badge
    Chapter 2 Dual acting and pan-PPAR activators as potential anti-diabetic therapies.
  4. Altmetric Badge
    Chapter 3 GLP-1 agonists and dipeptidyl-peptidase IV inhibitors.
  5. Altmetric Badge
    Chapter 4 Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes.
  6. Altmetric Badge
    Chapter 5 SGLT inhibitors as new therapeutic tools in the treatment of diabetes.
  7. Altmetric Badge
    Chapter 6 Inhibitors of 11β-hydroxysteroid dehydrogenase type 1 in antidiabetic therapy.
  8. Altmetric Badge
    Chapter 7 Nampt and its potential role in inflammation and type 2 diabetes.
  9. Altmetric Badge
    Chapter 8 Inhibition of ganglioside biosynthesis as a novel therapeutic approach in insulin resistance.
  10. Altmetric Badge
    Chapter 9 Overcoming Insulin Resistance with Ciliary Neurotrophic Factor
  11. Altmetric Badge
    Chapter 10 Thermogenesis and related metabolic targets in anti-diabetic therapy.
  12. Altmetric Badge
    Chapter 11 Interleukin-targeted therapy for metabolic syndrome and type 2 diabetes.
  13. Altmetric Badge
    Chapter 12 Fructose-1, 6-bisphosphatase inhibitors for reducing excessive endogenous glucose production in type 2 diabetes.
  14. Altmetric Badge
    Chapter 13 AMP-activated protein kinase and metabolic control.
  15. Altmetric Badge
    Chapter 14 Mitochondria as potential targets in antidiabetic therapy.
  16. Altmetric Badge
    Chapter 15 Research and development of glucokinase activators for diabetes therapy: theoretical and practical aspects.
  17. Altmetric Badge
    Chapter 16 Erratum to Chapter 11: Interleukin-Targeted Therapy for Metabolic Syndrome and Type 2 Diabetes
Attention for Chapter 3: GLP-1 agonists and dipeptidyl-peptidase IV inhibitors.
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

patent
1 patent

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
36 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
GLP-1 agonists and dipeptidyl-peptidase IV inhibitors.
Chapter number 3
Book title
Diabetes - Perspectives in Drug Therapy
Published in
Handbook of experimental pharmacology, January 2011
DOI 10.1007/978-3-642-17214-4_3
Pubmed ID
Book ISBNs
978-3-64-217213-7, 978-3-64-217214-4
Authors

Baptist Gallwitz

Editors

Prof.Dr.Dr. Mathias Schwanstecher

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 36 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 36 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 6 17%
Student > Ph. D. Student 5 14%
Student > Bachelor 5 14%
Student > Doctoral Student 4 11%
Student > Postgraduate 3 8%
Other 8 22%
Unknown 5 14%
Readers by discipline Count As %
Medicine and Dentistry 14 39%
Nursing and Health Professions 6 17%
Agricultural and Biological Sciences 3 8%
Pharmacology, Toxicology and Pharmaceutical Science 2 6%
Biochemistry, Genetics and Molecular Biology 2 6%
Other 3 8%
Unknown 6 17%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 October 2019.
All research outputs
#7,491,592
of 22,899,952 outputs
Outputs from Handbook of experimental pharmacology
#227
of 649 outputs
Outputs of similar age
#54,501
of 181,058 outputs
Outputs of similar age from Handbook of experimental pharmacology
#9
of 22 outputs
Altmetric has tracked 22,899,952 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 649 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.2. This one has gotten more attention than average, scoring higher than 52% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 181,058 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 22 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.